These findings implicate CCL5, CCR3/CCR5, and ERK1/2 survival signaling pathways as potential therapeutic targets for clearing persistent ZIKV infections and preventing ZIKV spread and neurovirulence. Here, CCR5 is linked to Zika virus infectious disease.